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Pluripotent stem cells derived from both embryonic
and reprogrammed somatic cells have significant
potential for human regenerative medicine. Despite
similarities in developmental potential, however,
several groups have found fundamental differences
between embryonic stem cell (ESC) and induced-
pluripotent stem cell (iPSC) lines that may have
important implications for iPSC-based medical ther-
apies. Using an unsupervised clustering algorithm,
we further studied the genetic homogeneity of iPSC
and ESC lines by reanalyzing microarray gene
expression data from seven different laboratories.
Unexpectedly, this analysis revealed a strong corre-
lation between gene expression signatures and
specific laboratories in both ESC and iPSC lines.
Nearly one-third of the genes with lab-specific ex-
pression signatures are also differentially expressed
between ESCs and iPSCs. These data are consistent
with the hypothesis that in vitro microenvironmental
context differentially impacts the gene expression
signatures of both iPSCs and ESCs.
INTRODUCTION
Human embryonic stem cells (hESCs), originating from blasto-
cysts, have great potential both for regenerative medicine and
for elucidating fundamental aspects of human developmental
biology. In recent years, the reprogramming of human somatic
cells to create induced pluripotent stem cells (hiPSCs) has
emerged as a potential alternative to hESCs that may overcome
both ethical issues and potential genetic incompatibility prob-
lems in clinical applications (Takahashi et al., 2007). Currently,
two-, three-, and four-factor transgene-containing, and factor-
free hiPSCs are being intensively studied, and important roles
for critical genes (e.g., p53, see Zhao et al., 2008) are being
articulated. Although iPSCs have similar developmental poten-
tial to ESCs, aswas rigorously demonstrated by the birth of fertile
mice derived from iPSCs implanted into tetraploid embryos,
successful iPSC reprogramming remains inefficient (Zhao
et al., 2008, Hu et al., 2010). In addition, several studies have
reported distinct gene expression differences between iPSCs258 Cell Stem Cell 7, 258–262, August 6, 2010 ª2010 Elsevier Inc.and ESCs of both human and mouse origin (Chin et al., 2009,
Marchetto et al., 2009, and see Dolgin, 2010). Given the utility
and fast pace of pluripotent stem cell research, as well as the
reported differences between ESC and iPSC types, it is critical
to evaluate the degree to which iPSC and ESCs display well-
defined, invariant gene expression patterns across different
laboratories and culture conditions.RESULTS AND DISCUSSION
In a recent meta-analysis of iPSC and ESC gene expression
profiles, Chin et al. (2009) identified 15 genes that display consis-
tent differential expression between early passage hiPSC and
hESC lines across four different laboratories, and concluded
that at least some differential expression between iPSCs and
ESCs is not stochastic. Strikingly, when rendered as a heat
map, most of these 15 genes do not show consistent up- or
downregulation across these four laboratories (Figure 1 and
Figure S1 available online), and as shown in Figure 2 of Chin
et al., less than 50%, and as little as 10%, of the hundreds (or
thousands) of differentially expressed iPSC/ESC genes were
found in common between labs. On the basis of this result, we
suggest that most of the differential expression between iPSCs
and ESCs is either stochastic in nature (e.g., Hanna et al.,
2009) or is caused by lab-specific differences in either the
reprogramming process, the progenitor cells used, micro-envi-
ronmental aspects of stem cell culture or handling, or some
combination of these factors.
To examine possible links between specific laboratories and
hESC/hiPSC gene expression signatures, we used a recently
developed clustering algorithm, called AutoSOME (Newman
and Cooper, 2010), to analyze unfiltered microarray data repre-
senting multiple pluripotent cell lines produced and cultured by
different stem cell laboratories (Table S1). We found that gene
probes with similar expression levels in all cell lines form the
largest cluster, representing the set of common pluripotency
genes and general housekeeping genes. Of the remaining
gene coexpression modules (Figure S2), the next three largest
clusters clearly partition the pluripotent cell lines into groups
reflecting their laboratory of origin (Figure 2A). Of these three
clusters, cluster 2 contains genes upregulated in pluripotent
stem cells primarily from the Soldner et al. (2009) data set,
whereas cluster 3 contains genes similarly upregulated in the
Yu et al. (2009) and Ebert et al. (2009) data sets, both of which
derive from the Wisconsin laboratory. Finally, the Masaki et al.
Figure 1. Genes Differentially Expressed between Early Passage
hiPSC and hESC Lines across Four Laboratories, as Reported by
Chin et al.
The average log2 iPS/ES expression ratios for the 15 genes found by Chin et al.
(2009) to represent a conserved hiPSC signature across four laboratories (their
Table S5) is shown on the left, and data from two additional labs (three inde-
pendent experiments) is shown on the right. We include expression data
from Chin et al. Table S2, which has additional ESC and iPSC lines compared
to the Gene Expression Omnibus (GEO) microarray data set relating to Chin
et al. (GSE16654). All GEO data sets were RMA-normalized together (see
Experimental Procedures and Table S1),and were averaged across all probe
replicates for each gene and all cell lines for each cell type, hiPSC or hESC.
Chin et al. expression data were calculated separately for early passage
iPSC (hiPSC Early) and late passage iPSC (hiPSC Late) lines. Differential
expression was then computed as the mean iPSC expression over hESC
expression. Java TreeView (Saldanha, 2004) was used to render the heat
map. See also Figure S1.
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Lab-Specific Gene Expression in Stem Cells(2007) and Park et al. (2008) data sets are clearly distinguished
from the other data sets by genes composing cluster 4. Consis-
tent with this observation, gene expression values within these
three coexpression clusters are statistically more highly corre-
lated between hiPSCs and hESCs from the same lab-specific
clusters (Pearson’s rho > 0.9) than between lab-specific clusters
(Figure 2B). When mapped onto the same three clusters, such
lab-specific expression signatures are absent in fibroblasts lines,
where expression patterns are highly correlated between labs
(rho > 0.9; Figure 2B).We further analyzed gene clusters 2–4 for the presence of
genes found by Chin et al. to be differentially expressed between
iPSCs and ESCs. Remarkably, almost 30% of all genes found in
these three clusters are also differentially expressed between
hESC and early passage hiPSC types (see Venn diagram of
Figure 2A). This overlap is highly statistically significant (Fisher’s
exact test, p = 2.3E-12), indicating that factors causing the
observed lab-specific variation also impact the previously
reported gene expression differences distinguishing hESCs
from early passage hiPSCs. In addition, 16% of genes found to
be differentially expressed between early passage and late
passage hiPSCs and hESCs also significantly overlap with
clusters 2–4 (p = 1.9E-5) (Table S2). Indeed, all gene sets
made available by Chin et al. that exhibit differential expression
between hiPSCs and hESCs significantly overlap with clusters
2–4 (Table 1).
To ascertain whether the observed lab-specific expression
signatures are also evident at the transcriptome level, we
analyzed an extended meta-data set that includes a total of 17
hESC lines, 67 hiPSC lines, and 18 fibroblast lines from a total
of eight reprogramming experiments carried out in seven labora-
tories (Table S1). As visualized by a fuzzy cluster network
diagram in Figure 3, eight whole-transcriptome clusters were
identified (clusters 0–7). The transcriptomes of 17 of 18 fibroblast
cell lines clearly cluster together (cluster 3), whereas the gene
expression profile of the remaining fibroblast line, neonatal
fibroblast BJ1 47 (cluster 1), is virtually identical to hiPSCs,
consistent with a possible misannotation. Remarkably, the
transcriptomes of different hiPSC and hESC lines do not form
a single cluster, nor do they form two clusters separating hiPSCs
and hESCs. Rather, the stem cell transcriptomes generally form
distinct clusters based on the laboratory of origin, and indeed,
the same lab-specific expression signatures identified by
coexpression analysis are observed (see Figure 2).
Although differential stem cell transcriptome profiles clearly
distinguish most labs, including the Wisconsin lab (cluster 0),
Jaenisch lab (cluster 2), and Cowan/Hochedlinger labs (clusters
4 and 7), intriguingly, expression signatures from some labs
cluster together (all stem cell lines from Park et al., 2008, and
Maherali et al., 2008, and hiPSC line 18 of Chin et al., 2009),
revealing a common global transcriptome signature among
some independently cultured cell lines. Determining the basis
of such genetic homogeneity remains an important direction
for future experimental research.
In conclusion, we completed a large meta-analysis of the
genetic homogeneity of human pluripotent stem cells and found
a significant correlation between gene expression signatures of
pluripotent stem cells and their laboratory of origin. Coexpres-
sion analysis identified coregulated gene sets that positively
correlate with lab-specific gene classes, and that contain a large
fraction of genes differentially expressed between hESCs and
hiPSCs. These data indicate that hiPSCs and hESCs may
respond differently to their in vitro context and that lab-specific
expression patterns overshadow gene expression differences
between iPSCs and ESCs (Figures 2 and 3). It is well established
that different ESC lines exhibit significant variation (Allegrucci
and Young, 2007, Tavakoli et al., 2009), and it was recently
demonstrated that significant variation also exists among iPSCs
derived and cultured within the same laboratory (Masaki et al.,Cell Stem Cell 7, 258–262, August 6, 2010 ª2010 Elsevier Inc. 259
Figure 2. Pluripotent Stem Cell Genes Cluster with Laboratory of Origin
(A) Gene expression heat map showing the three largest gene expression clusters obtained from clustering the hiPSC and hESC metadata set (Table S1) have
patterns that reflect lab-specific clusters (Soldner et al., 2009; Yu et al., 2009 (Yu1 = GSE15175, Yu2 = GSE15176) and Ebert et al., 2009; Masaki et al., 2007, and
Park et al., 2008). The Venn diagram shows that 456 of the 1532 genes found in these three gene clusters are also differentially expressed between hESCs and
early passage hiPSCs, a statistically significant overlap as determined by Fisher’s exact test (p < 1011). All 1532 genes are provided in Table S2. For genes that
overlap with genes reported by Chin et al., see Table S3. (To construct the heat map, we applied median-centering to the RMA-normalized expression profiles of
all 1878 [of 2454] probeswith corresponding HUGOgene symbols [identifiedwith the HG-U133plus2 legend]. Java TreeView [Saldanha, 2004] was used to render
the heat map.) See also Figure S2.
(B) Pearson correlation analysis of all 1878 probes from (A) showing that pluripotent cell lines within lab-specific clusters have correlation values > 0.9, indicating
that in vitro context influences gene expression patterns in both human iPSCs and ESCs.
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results are consistent with the hypothesis that some, as yet
unidentified, microenvironmental features can impart distinct
lab-specific genetic signatures on both hiPSCs and hESCs,
and this might help explain the large variation between labs
shown in Figures 2 and 3 and in Figure 2 of Chin et al. (2009).
Experimental oxygen concentration is one candidate parameter
that may play an integral role in this regard (Csete, 2005). In light
of these results, we suggest that further characterization of the
interplay between culture environment and gene expression in
pluripotent stem cells is warranted.260 Cell Stem Cell 7, 258–262, August 6, 2010 ª2010 Elsevier Inc.EXPERIMENTAL PROCEDURES
Data Sets
All analyzed microarray data sets shown in Table S1 were downloaded from
the Gene Expression Omnibus (GEO) at http://www.ncbi.nlm.nih.gov/geo/.
For coexpression analysis, raw CEL files were downloaded for six HG-
U133plus2 (Affymetrix) microarray platform datas ets (GSE9709, GSE9832,
GSE13828, GSE14711, GSE15175, and GSE15176), combined into a single
meta-data set, and normalized with Robust Multi-Chip Averaging (RMA) with
the Affymetrix Expression Console software. For transcriptome analysis, three
additional microarray data sets were obtained (GSE12390, GSE16093, and
GSE16654), added to the previous six data sets (CEL files), and RMA
Table 1. Overlap between Lab-Specific Coexpression Clusters and Chin et al. Gene Sets
Early Passage
(3947 Genes)
Late Passage
(860 Genes)
Early/Late Passage
(318 Genes)
All Four Experiments
(15 Genes)
Mouse
(294 Genes)
Random
(2000 Genes)
Number of Genes
Shared (p Value)
456 (2.3E-12) 112 (1.3E-5) 51 (1.9E-5) 5 (7.1E-3) 44 (2.2E-4) 180 (.61)
Overlap and statistical significance of all published Chin et al. (2009) data sets containing genes differentially expressed between iPSCs and ESCs
(Tables S2–S6 from Chin et al. denoted by ‘‘Early Passage,’’ ‘‘Late Passage,’’ ‘‘Early/Late Passage,’’ ‘‘All Four Experiments,’’ and ‘‘Mouse,’’ respec-
tively) compared to 1532 genes from coexpression clusters 2–4 (see Figure 2, also refer to Table S3 for all overlapping genes). Overlap of clusters 2–4
with a set of 2000 genes randomly drawn from the Affymetrix HG-U133plus2 chip set is also shown. p values were calculated with Fisher’s exact test
with n = 17,620 genes (as reported by Chin et al., 2009).
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expressed between iPSCs and ESCs were downloaded from Tables S2–S6
in Chin et al. (2009).
Microarray Analysis Methods
Computational Methods
Whole-genome microarray analyses depend upon the use of computational
and statistical data mining methods to identify significant gene expression
patterns. Commonly used data clustering tools (e.g., Eisen et al., 1998) requireFigure 3. Lab-Specific Differences Rendered as a Fuzzy Cluster Netwo
Whole-transcriptome clustering of hiPSC lines, hESC lines, and fibroblast cell li
distinct laboratory-specific gene expression patterns of pluripotent stem cells (
network of AutoSOME clustering results contains seven pluripotent stem cell clust
(fibroblasts = diamond nodes). All nodes are numbered by cluster label and are co
blue = Yu et al., 2009, GSE15176 data set; yellow-green = Ebert et al., 2009, GSE1
et al., 2007, GSE9709 data set; red = Park et al., 2008, GSE9832 data set; oran
GSE16093 data set; purple = Chin et al., 2009, GSE16654 data set). The cor
The GSE15175, GSE15176 and GSE13828 data sets are all from the Wisconsin la
expression data (see Table S1). Edges between nodes (cell lines) are weighted by
clustering, ranging from low similarity (thin, red edge) to high similarity (thick, blue
2003).external prediction methods or user input to identify cluster number and often
involve elimination of many genes based on an arbitrary differential expression
threshold. To overcome these limitations, we developed a powerful computa-
tional method, implemented as an algorithm called AutoSOME, that robustly
identifies natural data structures in large noisy data sets, including data from
microarray experiments, without prior knowledge of cluster number. We previ-
ously showed that AutoSOME transcriptome analysis effectively identified
cell-cell variation among well-characterized cancer cell lines, and AutoSOME
gene co-expression analysis identified a set of 3400 coregulated genesrk
nes from eight reprogramming experiments and nine GEO data sets showing
refer to Table S1 for details of the analyzed metadata set). The fuzzy cluster
ers (hiPSCs = circular nodes; hESCs = square nodes) and one fibroblast cluster
lored by GEO data set (light blue = Yu et al., 2009, GSE15175 data set; medium
3828 data set; green = Soldner et al., 2009, GSE14711 data set; pink = Masaki
ge = Maherali et al., 2008, GSE12390 data set; dark blue = Kim et al., 2009,
responding authors for each publication and data set are listed in the key.
b, and all three GSE data sets utilize the same embryonic stem cell microarray
the pairwise similarity of cell lines as determined by AutoSOME transcriptome
edge). The cluster network was rendered with Cytoscape 2.6.0 (Shannon et al.,
Cell Stem Cell 7, 258–262, August 6, 2010 ª2010 Elsevier Inc. 261
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network composed of 1165 genes (Newman andCooper, 2010). These results,
alongwith extensive benchmarking studies, demonstrate that AutoSOME is an
effective and unbiased approach for identifying gene expressionmodules from
whole-genome microarray data.
Clustering and Gene Set Comparison
For coexpression clustering, we processed the hiPS/hESC/Fib data set
(as specified in Table S1) to remove all fibroblast lines, applied median-
centering across all 54,675 gene probes and 62 arrays, and normalized all
arrays to unit variance. AutoSOME coexpression analysis was run on the
normalized, unfiltered data set with 100 ensemble iterations and default
parameters as previously described (Newman and Cooper, 2010). For
comparison with gene sets from Chin et al., probes in clusters 2–4 were
collapsed with the HG-U133plus2 legend into 1532 genes (Table S2), and
only exact matches among reference sequence identifiers were counted
(Table S3). For transcriptome clustering, the extended, unfiltered meta-data
set (Table S1) was median centered over all probes and normalized to unit
variance over all arrays, converted into a distance matrix with Euclidean
distance, and normalized to unit variance over the distance matrix. AutoSOME
transcriptome analysis was then applied to the distance matrix with 500
ensemble iterations with default parameters, and the results were visualized
as a fuzzy cluster network (see Newman and Cooper, 2010).
Statistical Methods
Within the lab-specific groups we identified (Figure 2), the RMA-normalized
expression profiles for each pluripotent cell type, hESC or hiPSC, were
averaged together for all 1878 of 2454 probes having HUGO symbols from
clusters 2–4 (identified using the HG-U133plus2 legend). Likewise, genes
from clusters 2–4 from all fibroblast cell lines were averaged together into
expression vectors for the same lab-specific groups as pluripotent stem cells.
The correlation table in Figure 2B shows Pearson correlations of an all-against-
all comparison of these expression vectors. For computation of the statistical
significance of overlapping gene sets (Figure 2A, Table 1), Fisher’s one-sided
exact test was used with n = 17,620 genes (entire Affymetrix HG-U133plus2
microarray platform). Although collapsing the HUGO gene annotation of
the HG-U133plus2 platform yields n = 20,827 unique genes, we used the
same n reported by Chin et al. (2009) to promote a fair statistical analysis of
overlapping gene sets. All statistical tests were performed with R.SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures and three tables and can be
found with this article online at doi:10.1016/j.stem.2010.06.016.
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